BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simeonova R, Zheleva D, Valkova I, Stavrakov G, Philipova I, Atanasova M, Doytchinova I. A Novel Galantamine-Curcumin Hybrid as a Potential Multi-Target Agent against Neurodegenerative Disorders. Molecules 2021;26:1865. [PMID: 33806197 DOI: 10.3390/molecules26071865] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Mettai M, Daoud I, Mesli F, Kenouche S, Melkemi N, Kherachi R, Belkadi A. Molecular docking/dynamics simulations, MEP analysis, bioisosteric replacement and ADME/T prediction for identification of dual targets inhibitors of Parkinson's disease with novel scaffold. In Silico Pharmacol 2023;11:3. [PMID: 36687301 DOI: 10.1007/s40203-023-00139-3] [Reference Citation Analysis]
2 Khan FB, Singh P, Jamous YF, Ali SA, Abdullah, Uddin S, Zia Q, Jena MK, Khan M, Owais M, Huang CY, Chanukuppa V, Ardianto C, Ming LC, Alam W, Khan H, Ayoub MA. Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review. Cancers (Basel) 2022;15. [PMID: 36612248 DOI: 10.3390/cancers15010249] [Reference Citation Analysis]
3 Simeonova R, Atanasova M, Stavrakov G, Philipova I, Doytchinova I. Ex Vivo Antioxidant and Cholinesterase Inhibiting Effects of a Novel Galantamine-Curcumin Hybrid on Scopolamine-Induced Neurotoxicity in Mice. Int J Mol Sci 2022;23. [PMID: 36499171 DOI: 10.3390/ijms232314843] [Reference Citation Analysis]
4 Ribeiro TC, Sábio RM, Luiz MT, de Souza LC, Fonseca-Santos B, Cides da Silva LC, Fantini MCA, Planeta CDS, Chorilli M. Curcumin-Loaded Mesoporous Silica Nanoparticles Dispersed in Thermo-Responsive Hydrogel as Potential Alzheimer Disease Therapy. Pharmaceutics 2022;14:1976. [PMID: 36145723 DOI: 10.3390/pharmaceutics14091976] [Reference Citation Analysis]
5 Rao P, Goswami D, Rawal RM. Extending the lore of curcumin as dipteran Butyrylcholine esterase (BChE) inhibitor: A holistic molecular interplay assessment. PLoS One 2022;17:e0269036. [PMID: 35617284 DOI: 10.1371/journal.pone.0269036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Jana A, Bhattacharjee A, Das SS, Srivastava A, Choudhury A, Bhattacharjee R, De S, Perveen A, Iqbal D, Gupta PK, Jha SK, Ojha S, Singh SK, Ruokolainen J, Jha NK, Kesari KK, Ashraf GM. Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer's Disease. Mol Neurobiol 2022. [PMID: 35347587 DOI: 10.1007/s12035-022-02779-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Séguy L, Groo A, Malzert-fréon A. How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer’s disease treatment? Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.02.022] [Reference Citation Analysis]
8 Mukherjee S, Mishra AK, Peer GDG, Bagabir SA, Haque S, Pandey RP, Raj VS, Jain N, Pandey A, Kar SK. The Interplay of the Unfolded Protein Response in Neurodegenerative Diseases: A Therapeutic Role of Curcumin. Front Aging Neurosci 2021;13:767493. [PMID: 34867295 DOI: 10.3389/fnagi.2021.767493] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Juszczyk G, Mikulska J, Kasperek K, Pietrzak D, Mrozek W, Herbet M. Chronic Stress and Oxidative Stress as Common Factors of the Pathogenesis of Depression and Alzheimer's Disease: The Role of Antioxidants in Prevention and Treatment. Antioxidants (Basel) 2021;10:1439. [PMID: 34573069 DOI: 10.3390/antiox10091439] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
10 Rao P, Goswami D, Rawal RM. Revealing the molecular interplay of curcumin as Culex pipiens Acetylcholine esterase 1 (AChE1) inhibitor. Sci Rep 2021;11:17474. [PMID: 34471175 DOI: 10.1038/s41598-021-96963-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
11 Mladenova K, Stavrakov G, Philipova I, Atanasova M, Petrova S, Doumanov J, Doytchinova I. A Galantamine-Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells. Int J Mol Sci 2021;22:7592. [PMID: 34299209 DOI: 10.3390/ijms22147592] [Reference Citation Analysis]
12 Stavrakov G, Philipova I, Lukarski A, Atanasova M, Georgiev B, Atanasova T, Konstantinov S, Doytchinova I. Discovery of a Novel Acetylcholinesterase Inhibitor by Fragment-Based Design and Virtual Screening. Molecules 2021;26:2058. [PMID: 33916760 DOI: 10.3390/molecules26072058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]